How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health Impact.
<h4>Background</h4>Randomized controlled trials reported that pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine rarely selects for drug resistance. However, drug resistance due to PrEP is not completely understood. In daily practice, PrEP will not be used under the well-co...
Saved in:
| Main Authors: | Dobromir T Dimitrov, Marie-Claude Boily, Timothy B Hallett, Jan Albert, Charles Boucher, John W Mellors, Deenan Pillay, David A M C van de Vijver |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0158620&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness.
by: Dobromir Dimitrov, et al.
Published: (2013-01-01) -
Dosing forgiveness of oral PrEP for cisgender women remains uncertain
by: Mia Moore, et al.
Published: (2025-05-01) -
HIV‐1 testing in the context of expanding PrEP modalities
by: Urvi M. Parikh, et al.
Published: (2025-07-01) -
Estimated impact of long‐acting injectable PrEP in South Africa: a model comparison analysis
by: Sarah E. Stansfield, et al.
Published: (2025-07-01) -
Understanding PrEP misconceptions and their impact on PrEP initiation and use among pregnant and lactating women in Malawi.
by: Alinda M Nyamaizi, et al.
Published: (2025-01-01)